- PRICING
- LIVE QUOTES
- LEARN
- HELP
EN
3 Unpopular Stocks That Concern Us
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Whatever the consensus opinion may be, our team at StockStory cuts through the noise by conducting independent analysis to determine a company’s long-term prospects. That said, here are three stocks where the skepticism is well-placed and some better opportunities to consider.
Teradata (TDC)
Consensus Price Target: $35.50 (13.2% implied return)
Pioneering data warehousing technology in the 1980s before "big data" was a common term, Teradata (NYSE:TDC) provides cloud-based data analytics and AI platforms that help large enterprises integrate, analyze, and leverage their data across multiple environments.
Why Should You Sell TDC?
- Offerings struggled to generate meaningful interest as its average billings growth of 3.7% over the last year did not impress
- Operating profits fell over the last year as its sales dropped and it struggled to adjust its fixed costs
- Projected 20.2 percentage point decline in its free cash flow margin next year reflects the company’s plans to increase its investments to defend its market position
At $31.36 per share, Teradata trades at 1.8x forward price-to-sales. To fully understand why you should be careful with TDC, check out our full research report (it’s free).
Medifast (MED)
Consensus Price Target: $12 (12.9% implied return)
Known for its Optavia program that combines portion-controlled meal replacements with coaching, Medifast (NYSE:MED) has a broad product portfolio of bars, snacks, drinks, and desserts for those looking to lose weight or consume healthier foods.
Why Do We Think MED Will Underperform?
- Products have few die-hard fans as sales have declined by 39.1% annually over the last three years
- Smaller revenue base of $346.1 million means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
- Falling earnings per share over the last three years has some investors worried as stock prices ultimately follow EPS over the long term
Medifast’s stock price of $10.63 implies a valuation ratio of 0.4x forward price-to-sales. If you’re considering MED for your portfolio, see our FREE research report to learn more.
iHeartMedia (IHRT)
Consensus Price Target: $3.63 (-8.1% implied return)
Occasionally featuring celebrity hosts like Ryan Seacrest on its shows, iHeartMedia (NASDAQ:IHRT) is a leading multimedia company renowned for its extensive network of radio stations, digital platforms, and live events across the globe.
Why Should You Dump IHRT?
- Annual revenue growth of 6.5% over the last five years was below our standards for the consumer discretionary sector
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
- 8× net-debt-to-EBITDA ratio makes lenders less willing to extend additional capital, potentially necessitating dilutive equity offerings
iHeartMedia is trading at $3.95 per share, or 7.7x forward EV-to-EBITDA. Read our free research report to see why you should think twice about including IHRT in your portfolio.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.